PMID: 9444841Jan 28, 1998Paper

A ferrite core/metallic sheath thermoseed for interstitial thermal therapies

IEEE Transactions on Bio-medical Engineering
T C CetasY Contractor

Abstract

An alternative form of ferromagnetic seed for thermal therapy has been developed following Matsuki, Murakami, and their colleagues [1]-[4]. A nearly lossless ceramic ferrite core (FC) is surrounded by an electrically conductive sheath. The FC has a high relative intrinsic permeability, typically 3000 at low magnetic field strengths, and a sharp transition from the ferrimagnetic state to the nonmagnetic state. The sheath is either a metallic tube or coating on the core. When this composite seed is excited with a radiofrequency magnetic field, large eddy currents are induced in the metallic sheath (MS) due to the concentrated magnetic flux in the core leading to Joule heating. Advantages of this configuration are that this ferrite core/metallic sheath (FC/MS) thermoseed has high power absorption efficiency and a sharp transition compared to ferromagnetic alloy systems; means of optimizing efficiency are apparent from simple expressions; the outer sheath can be of any biocompatible metal; the production method for the ferrites leads to large quantities of seeds with reproducible properties. The FC/MS configuration solves many of the technical problems that have hindered the clinical implementation of thermally regulating ferromagn...Continue Reading

References

Jul 1, 1992·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·R A SteevesB R Paliwal
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·B SteaA Shetter
Nov 1, 1992·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·E R LeeD S Kapp
Jul 1, 1992·Medical Physics·Z P ChenT C Cetas
Sep 1, 1991·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Z P ChenT C Cetas
Jul 1, 1991·International Journal of Radiation Oncology, Biology, Physics·R B Chin, P R Stauffer
Jan 1, 1990·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·I A BrezovichM M Salter
Jan 1, 1990·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Z P ChenT C Cetas
Feb 1, 1990·International Journal of Radiation Oncology, Biology, Physics·D S ShimmT C Cetas
Apr 1, 1988·Journal of Biomedical Materials Research·J S ChenT C Cetas
May 1, 1988·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·K LamZ Petrovich
Dec 1, 1986·International Journal of Radiation Oncology, Biology, Physics·J A Mechling, J W Strohbehn
Jan 1, 1985·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·J M CossetJ A Dewar
Mar 1, 1971·IEEE Transactions on Bio-medical Engineering·C BurtonE Walker
Feb 1, 1984·IEEE Transactions on Bio-medical Engineering·P R StaufferR C Jones
Jan 1, 1984·IEEE Transactions on Bio-medical Engineering·W J AtkinsonD P Chakraborty
Jan 1, 1984·IEEE Transactions on Bio-medical Engineering·P R StaufferR B Roemer
Dec 1, 1982·Cancer·N VoraJ O Archambeau
Oct 15, 1995·International Journal of Radiation Oncology, Biology, Physics·R A SteevesW F Mieler
Jan 1, 1995·Medical Physics·J G MeijerJ D van Dijk
Oct 15, 1994·International Journal of Radiation Oncology, Biology, Physics·J H IndikT C Cetas
Sep 1, 1993·International Journal of Radiation Oncology, Biology, Physics·C F MackP R Stauffer
Jan 1, 1994·IEEE Transactions on Bio-medical Engineering·P R StaufferT L Phillips
May 1, 1993·IEEE Transactions on Bio-medical Engineering·S A HaiderR B Roemer
Apr 1, 1996·IEEE Transactions on Bio-medical Engineering·J A PaulusJ B Park
Jan 1, 1996·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·I TohnaiM Matsui

❮ Previous
Next ❯

Citations

Oct 6, 2006·IEEE Transactions on Bio-medical Engineering·Patrick R BuckleyDuncan J Maitland
Feb 17, 2015·Journal of Advanced Research·Salwa A M Abdel-HameedMohamed M Farag
Nov 4, 2016·Medical Physics·Gregory WarrellE Ishmael Parsai
Feb 6, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Amira M Gamal-EldeenMenha M Swellam
May 14, 2009·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·V A AtsarkinA R Kaul
Jun 8, 2000·Physics in Medicine and Biology·J J Lagendijk

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.